News Focus
News Focus
icon url

jav0033

11/01/23 10:46 AM

#437770 RE: DoTheRightThing #437759

Missling is a SOB and a MoRON.

Other Biotechs are eating our lunch with subpar science, but they have better Management and communication skills.
icon url

tredenwater2

11/01/23 11:05 AM

#437771 RE: DoTheRightThing #437759

Your naive, the stock would still be down 85% whether results came out or not. The sharks circling know its about approval and or revenue.

Dr. Missling is making sure the results are prepared the way the Fda likes to receive them (Kun Jin said as much recently) and supported by a 3rd party peer reviewed paper.

No need to reply, I understand your number one priority of concern is about your capital preservation. Its all about buying in at the right price (bottom) and the stock only goes up from there. Maybe BIIB would he a good fit, they are past due for a 20 billion dollar PR bump. You might also try SAVA or Annovis, both are beaten down pretty good and might be nearing entry with the above mentioned priority.